5‐alpha reductase inhibitors vs placebo
Prostatitis symptoms: 'responders' Number of participants with a 25% decrease in NIH‐CPSI scores · participants with chronic prostatitis/chronic pelvic pain syndrome
5‐alpha reductase inhibitors showed no clear difference in prostatitis symptoms: 'responders' Number of participants with a 25%… compared with placebo (low certainty).
1 finding from 1 review
- Pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome 2019 · Cochrane Headline outcomes onlyRR 2.13 [0.82, 5.53]1 study · 64 participantsLow